2021
DOI: 10.1016/j.bioorg.2021.105290
|View full text |Cite
|
Sign up to set email alerts
|

Anticancer effect evaluation in vitro and in vivo of iridium(III) polypyridyl complexes targeting DNA and mitochondria

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
11
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 27 publications
(11 citation statements)
references
References 81 publications
0
11
0
Order By: Relevance
“…The SGC-7901 cells were cultured in six-well plates and treated with IC 50 concentrations of 3b and 3c for 24 h. The cells were lysed for 10 min and centrifuged to obtain the supernatant. The prepared ATP detection working solution was added into the supernatant, 5 min late, the RLU value was measured [ 42 ].…”
Section: Methodsmentioning
confidence: 99%
“…The SGC-7901 cells were cultured in six-well plates and treated with IC 50 concentrations of 3b and 3c for 24 h. The cells were lysed for 10 min and centrifuged to obtain the supernatant. The prepared ATP detection working solution was added into the supernatant, 5 min late, the RLU value was measured [ 42 ].…”
Section: Methodsmentioning
confidence: 99%
“…A variety of metal complexes have been developed that not only act on mitochondria but also can bind to DNA ( Figure 4 ), which can cause excessive DNA damage to kill cancer cells, including platinum complexes 26 and 27 [ 112 , 113 ], iridium complex 28 [ 114 ], and copper complex 29 [ 115 ]. Taking 27 as an important example, 27 can interact with DNA through groove binding and has the potential to break DNA [ 113 ].…”
Section: Anti-cancer Metal Complexes Activating Ros-mediated Signaling From Mitochondriamentioning
confidence: 99%
“…In addition, cyclometalated iridium(III) and rhenium(I) tricarbonyl complexes have been widely used in bioimaging and biosensing by virtue of their rich photophysical properties, e.g., high quantum yields, large Stokes shifts, long emission lifetimes, high photostability and cell permeability. [5][6][7][8][9][10] Many researchers have confirmed cyclometalated iridium (III) complexes to be promising alternatives to platinum-based drugs, because they possess multiple anticancer modes, such as catalyzing cellular redox reactions, [11][12][13] damaging specific subcellular organelles [14][15][16][17][18] and inhibiting protein activities. 19,20 In addition, the C^N ligands of cyclometalated iridium(III) complexes can effectively regulate their photophysical and photochemical properties, lipophilicities, molecular sizes, and so on.…”
Section: Introductionmentioning
confidence: 99%
“…19,20 In addition, the C^N ligands of cyclometalated iridium(III) complexes can effectively regulate their photophysical and photochemical properties, lipophilicities, molecular sizes, and so on. 16,[20][21][22] Chao et al reported that endoplasmic reticulum-targeted anticancer cyclometalated iridium (III) complexes initiated endoplasmic reticulum stress and induced immunogenic cell death. 23 The cyclometalated iridium(III) complexes synthesized by Liu et al induced apoptosis and autophagy in B16 cells through reactive oxygen species (ROS)-mediated mitochondrial dysfunction and inhibition of the AKT/mTOR pathway.…”
Section: Introductionmentioning
confidence: 99%